Table 1 Description of the nine PIM criteria used in this study
Criteria (country of origin) | Number of PIM statements | Age group | Year of the first published version | Year of the latest update |
|---|---|---|---|---|
Meds75+ database [13] (Finland) | 91 | ≥75 | 2010 | Continuously updated |
Beers criteria [24] (USA) | 46 | ≥65 | 1991 | 2019 |
EU(7)-PIM list [23] (Estonia, Finland, France, Germany, the Netherlands, Spain and Sweden) | 282 | ≥65a | 2015 | 2015 |
Indicators for Quality of Drug Therapy in the elderly [12] (Sweden) | 9 | ≥75 | 2004 | 2017 |
Laroche criteria [8] (France) | 34 | ≥75 | 2007 | 2007 |
NORGEP-NH [25] (Norway) | 34 | ≥70 | 2009 | 2015 |
PRISCUS list [22] (Germany) | 83 | ≥65 | 2010 | 2010 |
Red-Yellow-Green list [26] (Denmark) | 44 | ≥65 | 2011 | 2016 |
STOPP(/START) [27] (Ireland) | 114 | ≥65 | 2008 | 2015 |